5 Active Stocks: JetBlue Airways Corporation (NASDAQ:JBLU), Comcast Corporation (NASDAQ:CMCSA), Organovo Holdings (NYSEMKT:ONVO), Johnson & Johnson (NYSE:JNJ), Fred’s (NASDAQ:FRED)


JetBlue Airways Corporation (NASDAQ:JBLU) has added three nonstop routes from Washington, DC, to Florida, it announced this month. The flights, from Ronald Reagan Washington National Airport (DCA) to Fort Myers (RSW), Jacksonville (JAX), and West Palm Beach (PBI), FL, commenced on Dec. 18. JetBlue Airways Corporation (NASDAQ:JBLU) in last trading activity fell -3.61% to close at $15.22. Company weekly performance is -2.93% while its quarterly performance stands at 36.75%. JetBlue Airways Corporation (NASDAQ:JBLU) is -6.11% away from its 52 week high.

Comcast Corporation (NASDAQ:CMCSA), The Securities and Exchange Commission has divulged that Bacon Kenneth J, Director of Comcast Corp, had unloaded 3,000 shares at an average price of $55 in a transaction dated on December 15, 2014. The total value of the transaction was worth $165,000. On last trading day Comcast Corporation (NASDAQ:CMCSA) fell -2.42% to close at $55.96. Its volatility for the week is 2.10% while volatility for the month is 1.75%. CMCSA’s sales growth for past 5 years was 13.40% and its EPS growth for past 5 years was 24.40%. Comcast Corporation (NASDAQ:CMCSA) monthly performance is -2.07%.

Organovo Holdings Inc. (NASDAQ:ONVO) Insider Eric David sold 20,000 shares of the stock on the open market in a transaction that occurred on Tuesday, December 30th. The shares were sold at an average price of $7.55, for a total transaction of $151,000.00. Following the completion of the transaction, the insider now directly owns 681,306 shares in the company, valued at approximately $5,143,860. Organovo Holdings, Inc. (NYSEMKT:ONVO) has 1.10% insider ownership while its institutional ownership stands at 19.90%. In last trading activity company’s stock closed at $7.07.

Johnson & Johnson (NYSE:JNJ) announced the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies. The trial is being led by the Oxford Vaccine Group, part of the University of Oxford Department of Paediatrics. Johnson & Johnson (NYSE:JNJ) in last trading activity decreased -0.70% to close at $103.79. Company weekly performance is -1.21% while its quarterly performance stands at -0.63%. Johnson & Johnson (NYSE:JNJ) is -4.77% away from its 52 week high.

Fred’s Inc. (NASDAQ:FRED) has received an average rating of “Hold” from the nine analysts that are currently covering the company. On last trading day Fred’s, Inc. (NASDAQ:FRED) advanced 3.00% to close at $17.18. Its volatility for the week is 4.34% while volatility for the month is 4.53%. FRED’s sales growth for past 5 years was 1.50% and its EPS growth for past 5 years was 11.10%. Fred’s, Inc. (NASDAQ:FRED) monthly performance is 14.30%.


Leave a Reply

Your email address will not be published. Required fields are marked *